Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder (ASD)
Clinical trial NCT04644003 · COMPLETED
Trial details
- NCT number
- NCT04644003
- Sponsor
- Stalicla SA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2022-01-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.